NEW YORK, Dec. 20 (GenomeWeb News) - EpiVax has won a $993,771 Phase I SBIR grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop a smallpox vaccine, its second SBIR grant this year, the company said today.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.